UPMC Hillman Cancer Center | Strategic Alliance Partners

April 09, 2020

Adam M. Brufsky, MD, PhD, FACP, discusses the use of neratinib and the importance of expanding the treatment portfolio in HER2-positive metastatic breast cancer.

April 07, 2020

Lan G. Coffman, MD, PhD, assistant professor at the University of Pittsburgh Medical (UPMC) Center Hillman Cancer Center, discusses safety concerns with PARP inhibitors in ovarian cancer.

April 07, 2020

Michelle M. Boisen, MD, discusses criteria for selecting patients with ovarian cancer for upfront surgery versus neoadjuvant chemotherapy.

April 03, 2020

Alexander B. Olawaiye, MD, discusses the role of surgery in women with newly diagnosed ovarian cancer.

March 20, 2020

Adam M. Brufsky, MD, PhD, discusses case ascertainment bias regarding the coronavirus 2019.

March 04, 2020

Leisha A. Emens, MD, PhD, discusses the incidence and treatment of immune-related adverse events in ovarian cancer.

February 27, 2020

James M. Rossetti, DO, discusses symptom management for patients with myeloproliferative neoplasms.

February 25, 2020

John T. Comerci, MD, discusses the utility of primary debulking surgery in ovarian cancer.

February 22, 2020

James M. Rossetti, DO, discusses symptom management for patients with myeloproliferative neoplasms.

February 21, 2020

Leisha A. Emens, MD, PhD, discusses the combination of checkpoint inhibitors and PARP inhibitors in ovarian cancer.

February 20, 2020

Jason J. Luke, MD, FACP, discusses predictive biomarkers in metastatic melanoma.

February 13, 2020

Jessica Layne Berger, MD, discusses chemotherapy delivery options for patients with ovarian cancer.

February 05, 2020

Adam M. Brufsky, MD, PhD, FACP, discusses the emergence of biosimilars in oncology and how he anticipates they will change the paradigm.

January 29, 2020

Sarah E. Taylor, MD, discusses molecular testing recommendations in ovarian cancer.

January 29, 2020

Michelle M. Boisen, MD, discusses the selection of neoadjuvant chemotherapy versus upfront surgery for women with newly diagnosed ovarian cancer.

January 28, 2020

Brian Orr, MD, an assistant professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at University of Pittsburgh Medical Center, discusses ongoing biomarker research for immunotherapy in ovarian cancer.

January 11, 2020

Jessica Layne Berger, MD, discusses the frontline treatment options in newly diagnosed ovarian cancer.

January 07, 2020

Jason J. Luke, MD, FACP, discusses current and emerging treatment paradigms in metastatic melanoma.

December 23, 2019

Leisha A. Emens, MD, PhD, discusses a potential future with immunotherapy in ovarian cancer.

December 19, 2019

Adam M. Brufsky, MD, PhD, discusses the utility of trastuzumab biosimilars in breast cancer.